Software Platform Identifies and Characterizes Proteins and Peptides

A software platform was developed for the identification and characterization of proteins and peptides from mass spectrometry (MS) data.

Called Phenyx, the software was specifically designed to meet the concurrent demands of high-throughput MS data analysis and dynamic result assessment, while offering a flexible user-experience and adaptable architecture. It is available in multiple formats and installation configurations to insure its availability to the entire scientific community.

Phenyx was developed by Geneva Bioinformatics (GeneBio; Geneva, Switzerland) in collaboration with the Swiss Institute of Bioinformatics (SIB). GeneBio SA and GE Healthcare Life Sciences Latin America (GEHC-LS; São Paulo, Brazil) have announced a distribution agreement whereby GEHC-LS will distribute GeneBio's Phenyx MS identification platform throughout Latin America. This deal follows the long lasting relationship between GE Healthcare and GeneBio concerning the distribution of GeneBio's Melanie imaging platform.

Under the terms of the agreement, GEHC-LS will distribute Phenyx within the Latin American market as the exclusive MS software component of their product range. The deal encompasses GeneBio's Phenyx (for MS-MS identification), Aldente (for PMF analysis) as well as Phenyx's Daemon and other MS related software products that GeneBio will be marketing in the future.


Related Links:
Phenyx
Geneva Bioinformatics
GE Healthcare